iBio (IBIO) Receivables - Net (2016 - 2025)
iBio (IBIO) has disclosed Receivables - Net for 14 consecutive years, with $65000.0 as the latest value for Q3 2025.
- On a quarterly basis, Receivables - Net changed N/A to $65000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $65000.0, a N/A change, with the full-year FY2022 number at $1.0 million, down 90.2% from a year prior.
- Receivables - Net was $65000.0 for Q3 2025 at iBio, down from $5.1 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $10.2 million in Q2 2021 to a low of $65000.0 in Q3 2025.
- A 4-year average of $3.4 million and a median of $3.1 million in 2021 define the central range for Receivables - Net.
- Peak YoY movement for Receivables - Net: surged 13500.0% in 2021, then plummeted 90.2% in 2022.
- iBio's Receivables - Net stood at $5.1 million in 2021, then crashed by 80.98% to $970000.0 in 2022, then surged by 425.77% to $5.1 million in 2023, then tumbled by 98.73% to $65000.0 in 2025.
- Per Business Quant, the three most recent readings for IBIO's Receivables - Net are $65000.0 (Q3 2025), $5.1 million (Q1 2023), and $970000.0 (Q4 2022).